Prof. Armin Gerger provides the highlights on cancers of the liver, small intestine and pancreas tract from ESMO 2016
Cancer of the Liver, Small Intestine and Pancreas tract by Prof. Armin Gerger
Prof. Armin Gerger provides the highlights on cancers of the liver, small intestine and pancreas tract from ESMO 2016
Cancer of the Liver, Small Intestine and Pancreas tract by Prof. Armin Gerger
Since 2012 Dr Armin Gerger is professor at the Medial University in Graz, Austria. He works as a clinical oncologist and coordinates the Subcentre for Gastrointestinal Neoplasia at the Comprehensive Cancer Centre, Graz. He leads the Pharmacogenetics Research Unit, at the Division of Clinical Oncology of the Medical University of Graz, and the Area “Cancer” of the Centre for Biomarker Research in Medicine (CBmed). Dr Gerger’s research focuses on prognostic and predictive genetic biomarkers in gastrointestinal cancer, which he developed further as a research fellow at the Norris Comprehensive Cancer Centre of the University of Southern California. Dr Gerger’s research activity is mirrored in several papers in high-ranked scientific journals and significant extramural funding.
Expert insights into personalised treatment strategies in BRAF-mutated NSCLC
Insights and support for patients
Optimising treatment strategies and AE management
Navigating common treatment scenarios in HER2-mutant non-small cell lung cancer
An overview of the EMERALD subgroup analyses